MedPath
FDA Approval

Fluvastatin Sodium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 30, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fluvastatin(80 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluvastatin Sodium

Product Details

NDC Product Code
0093-7446
Application Number
ANDA079011
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 7, 2022
CROSPOVIDONE (15 MPA.S AT 5%)Inactive
Code: 68401960MKClass: IACT
HYDROXYETHYL CELLULOSE (5500 MPA.S AT 2%)Inactive
Code: M825OX60H9Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYETHYLENE GLYCOL 4000Inactive
Code: 4R4HFI6D95Class: IACT
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5PClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
Code: PYF7O1FV7FClass: ACTIMQuantity: 80 mg in 1 1
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990Class: IACT
© Copyright 2025. All Rights Reserved by MedPath